speb/financial-data huggingface dataset:
SURE.L balance_sheet (quarterly, 2025-03-31) — Capital Stock: 79479.00
SURE.L balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 5754.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 5754.00
SURE.L balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 5754.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 5754.00
SURE.L cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 0.00
SURE.L cash_flow (annual, 2025-03-31) — Change In Payable: 87648.00
SURE.L cash_flow (annual, 2025-03-31) — Change In Receivables: 4927.00
SURE.L cash_flow (annual, 2025-03-31) — Change In Working Capital: 92575.00
SURE.L cash_flow (annual, 2025-03-31) — Changes In Cash: -59455.00
SURE.L balance_sheet (annual, 2025-03-31) — Common Stock: 79479.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Common Stock: 79479.00
SURE.L balance_sheet (annual, 2025-03-31) — Common Stock Equity: 13972042.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 13972042.00
SURE.L cash_flow (annual, 2025-03-31) — Common Stock Issuance: 750000.00
SURE.L income_statement (annual, 2025-03-31) — Diluted Average Shares: 7540033.00
SURE.L income_statement (annual, 2025-03-31) — Diluted EPS: 0.99
SURE.L income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 7427812.00
SURE.L cash_flow (annual, 2025-03-31) — End Cash Position: 5754.00
SURE.L balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 14741288.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 14741288.00
SURE.L cash_flow (annual, 2025-03-31) — Financing Cash Flow: 764500.00
SURE.L cash_flow (annual, 2025-03-31) — Free Cash Flow: -311233.00
SURE.L cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -7940984.00
SURE.L income_statement (annual, 2025-03-31) — Gain On Sale Of Security: 0.00
SURE.L income_statement (annual, 2025-03-31) — General And Administrative Expense: 285468.00
SURE.L income_statement (annual, 2025-03-31) — Interest Expense: 34507.00
SURE.L income_statement (annual, 2025-03-31) — Interest Income: 0.00
SURE.L balance_sheet (annual, 2025-03-31) — Invested Capital: 14412042.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Invested Capital: 14412042.00
SURE.L cash_flow (annual, 2025-03-31) — Investing Cash Flow: -512722.00
SURE.L balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 14741288.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 14741288.00
SURE.L balance_sheet (annual, 2025-03-31) — Investments And Advances: 14741288.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 14741288.00
SURE.L cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 750000.00
SURE.L cash_flow (annual, 2025-03-31) — Issuance Of Debt: 40000.00
SURE.L balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 440000.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 440000.00
SURE.L cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 40000.00
SURE.L cash_flow (annual, 2025-03-31) — Long Term Debt Payments: 0.00
SURE.L cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 750000.00
SURE.L balance_sheet (annual, 2025-03-31) — Net Debt: 434246.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Net Debt: 434246.00
SURE.L cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 109364.00
SURE.L income_statement (annual, 2025-03-31) — Net Income: 1000000.00
SURE.L income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 7427812.00
SURE.L income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 7427812.00
SURE.L income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 7427812.00
SURE.L income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 7427812.00
SURE.L cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 7427812.00
SURE.L income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 7427812.00
SURE.L income_statement (annual, 2025-03-31) — Net Interest Income: -34507.00
SURE.L cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -512722.00
SURE.L cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 40000.00
SURE.L cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 40000.00
SURE.L cash_flow (annual, 2025-03-31) — Net Other Financing Charges: 0.00
SURE.L balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 13972042.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 13972042.00
SURE.L income_statement (annual, 2025-03-31) — Normalized Income: 7427812.00
SURE.L cash_flow (annual, 2025-03-31) — Operating Cash Flow: -311233.00
SURE.L income_statement (annual, 2025-03-31) — Operating Revenue: 1042987.22
SURE.L balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 7948130.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 7948130.00
SURE.L income_statement (annual, 2025-03-31) — Other Operating Expenses: 33833.00
SURE.L balance_sheet (annual, 2025-03-31) — Other Payable: 224246.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Other Payable: 224246.00
SURE.L balance_sheet (annual, 2025-03-31) — Payables: 224246.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Payables: 224246.00
SURE.L balance_sheet (annual, 2025-03-31) — Prepaid Assets: 0.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 0.00
SURE.L income_statement (annual, 2025-03-31) — Pretax Income: 7427812.00
SURE.L cash_flow (annual, 2025-03-31) — Purchase Of Investment: -512722.00
SURE.L balance_sheet (annual, 2025-03-31) — Receivables: 3600.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Receivables: 3600.00
SURE.L cash_flow (annual, 2025-03-31) — Repayment Of Debt: 0.00
SURE.L cash_flow (annual, 2025-03-31) — Sale Of Investment: 0.00
SURE.L income_statement (annual, 2025-03-31) — Selling General And Administration: 285468.00
SURE.L balance_sheet (annual, 2025-03-31) — Share Issued: 7948130.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Share Issued: 7948130.00
SURE.L balance_sheet (annual, 2025-03-31) — Stockholders Equity: 13972042.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 13972042.00
SURE.L balance_sheet (annual, 2025-03-31) — Tangible Book Value: 13972042.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 13972042.00
SURE.L income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
SURE.L income_statement (annual, 2025-03-31) — Tax Provision: 0.00
SURE.L income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.00
SURE.L balance_sheet (annual, 2025-03-31) — Total Assets: 14750642.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Total Assets: 14750642.00
SURE.L balance_sheet (annual, 2025-03-31) — Total Capitalization: 14412042.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 14412042.00
SURE.L balance_sheet (annual, 2025-03-31) — Total Debt: 440000.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Total Debt: 440000.00
SURE.L balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 13972042.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 13972042.00
SURE.L balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 778600.00
SURE.L balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 778600.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 7498183.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Capital Stock: 79479.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 173107.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 173107.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Common Stock: 79479.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 13514566.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 13460352.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 13460352.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 13460352.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 13514566.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 7948130.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Other Payable: 125243.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Payables: 125243.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Receivables: 6350.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Share Issued: 7948130.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 13514566.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 13514566.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Total Assets: 13639809.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 13514566.00
SURE.L balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 125243.00
SURG balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: -137218.00
SURG income_statement (annual, 2021-12-31) — Basic Average Shares: 4381709.00
SURG income_statement (annual, 2021-12-31) — Basic EPS: -3.09
SURG cash_flow (annual, 2021-12-31) — Capital Expenditure Reported: 0.00
SURG balance_sheet (annual, 2021-12-31) — Cash Financial: 6283496.00
SURG cash_flow (annual, 2021-12-31) — Change In Other Current Assets: 61458.00
SURG cash_flow (annual, 2021-12-31) — Change In Other Working Capital: -167050.00
SURG cash_flow (annual, 2021-12-31) — Common Stock Payments: 0.00
SURG balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 276250.00
SURG balance_sheet (annual, 2021-12-31) — Current Deferred Revenue: 276250.00
SURG balance_sheet (annual, 2021-12-31) — Current Notes Payable: 1553799.00
SURG income_statement (annual, 2021-12-31) — Diluted Average Shares: 4381709.00
SURG income_statement (annual, 2021-12-31) — Diluted EPS: -3.09
SURG balance_sheet (annual, 2021-12-31) — Duefrom Related Parties Current: 0.00
SURG cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: 42770.00
SURG cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: -1895871.00
SURG cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: -371664.00
SURG income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 1895871.00
SURG income_statement (annual, 2021-12-31) — Gain On Sale Of Security: -42770.00
SURG balance_sheet (annual, 2021-12-31) — Gross Accounts Receivable: 3387107.00
SURG cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 0.00
SURG balance_sheet (annual, 2021-12-31) — Investments And Advances: 443288.00
SURG balance_sheet (annual, 2021-12-31) — Investmentsin Associatesat Cost: 443288.00
SURG balance_sheet (annual, 2021-12-31) — Leases: 0.00
SURG balance_sheet (annual, 2021-12-31) — Line Of Credit: 0.00
SURG balance_sheet (annual, 2021-12-31) — Long Term Equity Investment: 443288.00
SURG balance_sheet (annual, 2021-12-31) — Net Debt: 908505.00
SURG cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: 0.00
SURG cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -2222952.00
SURG cash_flow (annual, 2021-12-31) — Operating Gains Losses: -2253441.00
SURG income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: -2280359.00
SURG income_statement (annual, 2021-12-31) — Other Special Charges: -377743.00
SURG balance_sheet (annual, 2021-12-31) — Preferred Stock: 260.00
SURG balance_sheet (annual, 2021-12-31) — Preferred Stock Equity: 260.00
SURG balance_sheet (annual, 2021-12-31) — Prepaid Assets: 0.00
SURG balance_sheet (annual, 2021-12-31) — Properties: 0.00
SURG cash_flow (annual, 2021-12-31) — Provisionand Write Offof Assets: 0.00
SURG cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: 0.00
SURG cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: 0.00
SURG income_statement (annual, 2022-12-31) — +Operating Expense: 12843390.00
SURG income_statement (annual, 2022-12-31) — +Total Revenue: 121544190.00
SURG balance_sheet (annual, 2022-12-31) — Accounts Payable: 5784374.00
SURG balance_sheet (annual, 2022-12-31) — Accounts Receivable: 9230365.00
SURG balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -445665.00
SURG balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 40780707.00
SURG balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -17525.00
SURG cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 653507.00
SURG cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 653507.00
SURG cash_flow (annual, 2022-12-31) — Asset Impairment Charge: -59485.00
SURG income_statement (annual, 2022-12-31) — Basic Average Shares: 12395364.00
SURG income_statement (annual, 2022-12-31) — Basic EPS: -0.05
SURG cash_flow (annual, 2022-12-31) — Beginning Cash Position: 6283496.00
SURG cash_flow (annual, 2022-12-31) — Capital Expenditure: -698582.00
SURG cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -387180.00
SURG balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 438903.00
SURG balance_sheet (annual, 2022-12-31) — Capital Stock: 14117.00
SURG balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 7035654.00
SURG balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 7035654.00
SURG balance_sheet (annual, 2022-12-31) — Cash Financial: 7035654.00
SURG cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 1457468.00
SURG cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1498582.00
SURG cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 793272.00
SURG cash_flow (annual, 2022-12-31) — Change In Account Payable: 154241.00
SURG cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 0.00
SURG cash_flow (annual, 2022-12-31) — Change In Inventory: -6878664.00
SURG cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 0.00
SURG cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 12968832.00
SURG cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -33140.00
SURG cash_flow (annual, 2022-12-31) — Change In Payable: 154241.00
SURG cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 154241.00
SURG cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -111524.00
SURG cash_flow (annual, 2022-12-31) — Change In Receivables: -5920991.00
SURG cash_flow (annual, 2022-12-31) — Change In Working Capital: 178754.00
SURG cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -5920991.00
SURG cash_flow (annual, 2022-12-31) — Changes In Cash: 752158.00
SURG balance_sheet (annual, 2022-12-31) — Common Stock: 14117.00
SURG balance_sheet (annual, 2022-12-31) — Common Stock Equity: 4990718.00
SURG cash_flow (annual, 2022-12-31) — Common Stock Issuance: 473.00
SURG income_statement (annual, 2022-12-31) — Cost Of Revenue: 108074782.00
SURG balance_sheet (annual, 2022-12-31) — Current Assets: 27563785.00
SURG balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 39490.00
SURG balance_sheet (annual, 2022-12-31) — Current Debt: 2650183.00
SURG balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 2689673.00
SURG balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 243110.00
SURG balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 243110.00
SURG balance_sheet (annual, 2022-12-31) — Current Liabilities: 23464062.00
SURG balance_sheet (annual, 2022-12-31) — Current Notes Payable: 1108150.00
SURG cash_flow (annual, 2022-12-31) — Depreciation: 335193.00
SURG cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 988700.00
SURG income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 931593.00
SURG cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 988700.00
SURG income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 931593.00
SURG income_statement (annual, 2022-12-31) — Diluted Average Shares: 12395364.00
SURG income_statement (annual, 2022-12-31) — Diluted EPS: -0.05
SURG income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -680763.00
SURG balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 1728721.00
SURG income_statement (annual, 2022-12-31) — EBIT: 1405572.00
SURG income_statement (annual, 2022-12-31) — EBITDA: 2394272.00
SURG income_statement (annual, 2022-12-31) — Earnings From Equity Interest: -89082.00
SURG cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 89082.00
SURG cash_flow (annual, 2022-12-31) — End Cash Position: 7035654.00
SURG cash_flow (annual, 2022-12-31) — Financing Cash Flow: 1457468.00
SURG cash_flow (annual, 2022-12-31) — Free Cash Flow: 94690.00
SURG cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 402970.00
SURG cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
SURG income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 0.00
SURG income_statement (annual, 2022-12-31) — General And Administrative Expense: 11652404.00
SURG balance_sheet (annual, 2022-12-31) — Goodwill: 1666782.00
SURG balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 4833939.00
SURG balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 9247890.00
SURG balance_sheet (annual, 2022-12-31) — Gross PPE: 1520390.00
SURG income_statement (annual, 2022-12-31) — Gross Profit: 13469408.00
SURG cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 0.00
SURG balance_sheet (annual, 2022-12-31) — Income Tax Payable: 0.00
SURG income_statement (annual, 2022-12-31) — Insurance And Claims: 1535687.00
SURG income_statement (annual, 2022-12-31) — Interest Expense: 1958800.00
SURG income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 1958800.00
SURG cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 523005.00
SURG balance_sheet (annual, 2022-12-31) — Inventory: 11186242.00
SURG balance_sheet (annual, 2022-12-31) — Invested Capital: 12662679.00
SURG cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1498582.00
SURG balance_sheet (annual, 2022-12-31) — Investments And Advances: 354206.00
SURG balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 354206.00
SURG cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 473.00
SURG cash_flow (annual, 2022-12-31) — Issuance Of Debt: 6700000.00
SURG balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 399413.00
SURG balance_sheet (annual, 2022-12-31) — Long Term Debt: 5021778.00
SURG balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 5421191.00
SURG cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 6700000.00
SURG cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -5243005.00
SURG balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 354206.00
SURG balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1089038.00
SURG balance_sheet (annual, 2022-12-31) — Minority Interest: 127535.00
SURG income_statement (annual, 2022-12-31) — Minority Interests: -127535.00
SURG cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -800000.00
SURG cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 473.00
SURG balance_sheet (annual, 2022-12-31) — Net Debt: 636307.00
SURG income_statement (annual, 2022-12-31) — Net Income: -680763.00
SURG income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -680763.00
SURG income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -553228.00
SURG income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -680763.00
SURG income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -680763.00
SURG cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -553228.00
SURG income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -553228.00
SURG cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -300000.00
SURG income_statement (annual, 2022-12-31) — Net Interest Income: -1958800.00
SURG cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 1456995.00
SURG cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 1456995.00
SURG income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -1958800.00
SURG balance_sheet (annual, 2022-12-31) — Net PPE: 1074725.00
SURG cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -11402.00
SURG balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 156779.00
SURG balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 0.00
SURG balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 0.00
SURG balance_sheet (annual, 2022-12-31) — Non Current Note Receivables: 176851.00
SURG income_statement (annual, 2022-12-31) — Normalized EBITDA: 1862362.00
SURG income_statement (annual, 2022-12-31) — Normalized Income: -1212673.00
SURG cash_flow (annual, 2022-12-31) — Operating Cash Flow: 793272.00
SURG cash_flow (annual, 2022-12-31) — Operating Gains Losses: 492052.00
SURG income_statement (annual, 2022-12-31) — Operating Income: 626018.00
SURG income_statement (annual, 2022-12-31) — Operating Revenue: 121544190.00
SURG balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 14116832.00
SURG balance_sheet (annual, 2022-12-31) — Other Current Assets: 111524.00
SURG balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 2650183.00
SURG balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 13018184.00
SURG income_statement (annual, 2022-12-31) — Other Gand A: 5335832.00
SURG income_statement (annual, 2022-12-31) — Other Income Expense: 779554.00
SURG balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 3167157.00
SURG cash_flow (annual, 2022-12-31) — Other Non Cash Items: -305239.00
SURG income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 336726.00
SURG balance_sheet (annual, 2022-12-31) — Other Properties: 431352.00
SURG income_statement (annual, 2022-12-31) — Other Special Charges: -524143.00
SURG balance_sheet (annual, 2022-12-31) — Payables: 7513095.00
SURG balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 7513095.00
SURG balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
SURG balance_sheet (annual, 2022-12-31) — Prepaid Assets: 111524.00
SURG income_statement (annual, 2022-12-31) — Pretax Income: -553228.00
SURG cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 473.00
SURG cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 51718.00
SURG cash_flow (annual, 2022-12-31) — Purchase Of Business: -800000.00
SURG cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -300000.00
SURG cash_flow (annual, 2022-12-31) — Purchase Of PPE: -11402.00
SURG balance_sheet (annual, 2022-12-31) — Receivables: 9230365.00
SURG income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 108017675.00
SURG income_statement (annual, 2022-12-31) — Reconciled Depreciation: 988700.00
SURG cash_flow (annual, 2022-12-31) — Repayment Of Debt: -5243005.00
SURG balance_sheet (annual, 2022-12-31) — Retained Earnings: -35804106.00
SURG income_statement (annual, 2022-12-31) — Salaries And Wages: 4780885.00
SURG income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 259393.00
SURG income_statement (annual, 2022-12-31) — Selling General And Administration: 11911797.00
SURG balance_sheet (annual, 2022-12-31) — Share Issued: 14116832.00
SURG income_statement (annual, 2022-12-31) — Special Income Charges: 531910.00
SURG cash_flow (annual, 2022-12-31) — Stock Based Compensation: 0.00
SURG balance_sheet (annual, 2022-12-31) — Stockholders Equity: 4990718.00
SURG balance_sheet (annual, 2022-12-31) — Tangible Book Value: 156779.00
SURG income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
SURG income_statement (annual, 2022-12-31) — Tax Provision: 0.00
SURG income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
SURG balance_sheet (annual, 2022-12-31) — Total Assets: 34003506.00
SURG balance_sheet (annual, 2022-12-31) — Total Capitalization: 10012496.00
SURG balance_sheet (annual, 2022-12-31) — Total Debt: 8110864.00
SURG balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 5118253.00
SURG income_statement (annual, 2022-12-31) — Total Expenses: 120918172.00
SURG balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 28885253.00
SURG balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 6439721.00
SURG balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 5421191.00
SURG income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 633785.00
SURG balance_sheet (annual, 2022-12-31) — Total Tax Payable: 0.00
SURG income_statement (annual, 2022-12-31) — Total Unusual Items: 531910.00
SURG income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 531910.00
SURG balance_sheet (annual, 2022-12-31) — Working Capital: 4099723.00
SURG income_statement (annual, 2022-12-31) — Write Off: -7767.00
SURG income_statement (annual, 2023-12-31) — +Operating Expense: 16777107.00
SURG income_statement (annual, 2023-12-31) — +Total Revenue: 137141832.00
SURG balance_sheet (annual, 2023-12-31) — Accounts Payable: 6439120.00
SURG balance_sheet (annual, 2023-12-31) — Accounts Receivable: 9536074.00
SURG balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -727197.00
SURG balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 43421019.00
SURG balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -17525.00
SURG cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 129060.00
SURG cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 129060.00
SURG cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 90009.00
SURG income_statement (annual, 2023-12-31) — Basic Average Shares: 14258172.00
SURG income_statement (annual, 2023-12-31) — Basic EPS: 1.45
SURG cash_flow (annual, 2023-12-31) — Beginning Cash Position: 7035654.00
SURG cash_flow (annual, 2023-12-31) — Capital Expenditure: -281304.00
SURG cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -281304.00
SURG balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 399413.00
SURG balance_sheet (annual, 2023-12-31) — Capital Stock: 14404.00
SURG balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 14622060.00
SURG balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 14622060.00
SURG balance_sheet (annual, 2023-12-31) — Cash Financial: 14622060.00
SURG cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -2419635.00
SURG cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -281304.00
SURG cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 10287345.00
SURG cash_flow (annual, 2023-12-31) — Change In Account Payable: -25751.00
SURG cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 570000.00
SURG cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: 570000.00
SURG cash_flow (annual, 2023-12-31) — Change In Inventory: 2139648.00
SURG cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -13057674.00
SURG cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -3058110.00
SURG cash_flow (annual, 2023-12-31) — Change In Payable: 544249.00
SURG cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 544249.00
SURG cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -50409.00
SURG cash_flow (annual, 2023-12-31) — Change In Receivables: -395718.00
SURG cash_flow (annual, 2023-12-31) — Change In Tax Payable: 570000.00
SURG cash_flow (annual, 2023-12-31) — Change In Working Capital: -13878014.00
SURG cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -395718.00
SURG cash_flow (annual, 2023-12-31) — Changes In Cash: 7586406.00
SURG balance_sheet (annual, 2023-12-31) — Common Stock: 14404.00
SURG balance_sheet (annual, 2023-12-31) — Common Stock Equity: 28249220.00
SURG cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
SURG cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
SURG income_statement (annual, 2023-12-31) — Cost Of Revenue: 101499341.00
SURG balance_sheet (annual, 2023-12-31) — Current Assets: 33366661.00
SURG balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 43137.00
SURG balance_sheet (annual, 2023-12-31) — Current Debt: 4584563.00
SURG balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 4627700.00
SURG balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 20000.00
SURG balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 20000.00
SURG balance_sheet (annual, 2023-12-31) — Current Liabilities: 12705044.00
SURG cash_flow (annual, 2023-12-31) — Depreciation: 978522.00
SURG cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 1107582.00
SURG income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 1064099.00
SURG cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1107582.00
SURG income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 1064099.00
SURG income_statement (annual, 2023-12-31) — Diluted Average Shares: 14922881.00
SURG income_statement (annual, 2023-12-31) — Diluted EPS: 1.38
SURG income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 20617903.00
SURG balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 1048224.00
SURG income_statement (annual, 2023-12-31) — EBIT: 18975587.00
SURG income_statement (annual, 2023-12-31) — EBITDA: 20083169.00
SURG income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 110203.00
SURG cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: -110203.00
SURG cash_flow (annual, 2023-12-31) — End Cash Position: 14622060.00
SURG cash_flow (annual, 2023-12-31) — Financing Cash Flow: -2419635.00
SURG cash_flow (annual, 2023-12-31) — Free Cash Flow: 10006041.00
SURG cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 576625.00
SURG income_statement (annual, 2023-12-31) — General And Administrative Expense: 15560157.00
SURG balance_sheet (annual, 2023-12-31) — Goodwill: 1666782.00
SURG balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 4332676.00
SURG balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 9553599.00
SURG balance_sheet (annual, 2023-12-31) — Gross PPE: 1476907.00
SURG income_statement (annual, 2023-12-31) — Gross Profit: 35642491.00
SURG income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
SURG cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 0.00
SURG balance_sheet (annual, 2023-12-31) — Income Tax Payable: 570000.00
SURG income_statement (annual, 2023-12-31) — Insurance And Claims: 1249556.00
SURG income_statement (annual, 2023-12-31) — Interest Expense: 595975.00
SURG income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 595975.00
SURG income_statement (annual, 2023-12-31) — Interest Income: 0.00
SURG income_statement (annual, 2023-12-31) — Interest Income Non Operating: 0.00
SURG cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 222326.00
SURG balance_sheet (annual, 2023-12-31) — Inventory: 9046594.00
SURG balance_sheet (annual, 2023-12-31) — Invested Capital: 33294306.00
SURG cash_flow (annual, 2023-12-31) — Investing Cash Flow: -281304.00
SURG balance_sheet (annual, 2023-12-31) — Investments And Advances: 464409.00
SURG balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 464409.00
SURG cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
SURG cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
SURG balance_sheet (annual, 2023-12-31) — Leases: 0.00
SURG balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 356276.00
SURG balance_sheet (annual, 2023-12-31) — Long Term Debt: 460523.00
SURG balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 816799.00
SURG cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
SURG cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -2626875.00
SURG balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 464409.00
SURG balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1089038.00
SURG balance_sheet (annual, 2023-12-31) — Minority Interest: 154244.00
SURG income_statement (annual, 2023-12-31) — Minority Interests: -26709.00
SURG cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
SURG cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
SURG income_statement (annual, 2023-12-31) — Net Income: 20617903.00
SURG income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 20617903.00
SURG income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 20644612.00
SURG income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 20617903.00
SURG income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 20617903.00
SURG cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 20644612.00
SURG income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 20644612.00
SURG cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 0.00
SURG income_statement (annual, 2023-12-31) — Net Interest Income: -595975.00
SURG cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 0.00
SURG cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -2626875.00
SURG cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -2626875.00
SURG income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -595975.00
SURG balance_sheet (annual, 2023-12-31) — Net PPE: 749710.00
SURG cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 0.00
SURG balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 23916544.00
SURG balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 2835000.00
SURG balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 2835000.00
SURG balance_sheet (annual, 2023-12-31) — Non Current Note Receivables: 176851.00
SURG income_statement (annual, 2023-12-31) — Normalized EBITDA: 20083169.00
SURG income_statement (annual, 2023-12-31) — Normalized Income: 20617903.00
SURG cash_flow (annual, 2023-12-31) — Operating Cash Flow: 10287345.00
SURG cash_flow (annual, 2023-12-31) — Operating Gains Losses: 466422.00
SURG income_statement (annual, 2023-12-31) — Operating Income: 18865384.00
SURG income_statement (annual, 2023-12-31) — Operating Revenue: 137141832.00
SURG balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 14403261.00
SURG balance_sheet (annual, 2023-12-31) — Other Current Assets: 161933.00
SURG balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 4584563.00
SURG income_statement (annual, 2023-12-31) — Other Gand A: 7967646.00
SURG income_statement (annual, 2023-12-31) — Other Income Expense: 110203.00
SURG balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 2665894.00
SURG cash_flow (annual, 2023-12-31) — Other Non Cash Items: 1290024.00
SURG balance_sheet (annual, 2023-12-31) — Other Properties: 387869.00
SURG balance_sheet (annual, 2023-12-31) — Payables: 8057344.00
SURG balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 8057344.00
SURG income_statement (annual, 2023-12-31) — Pretax Income: 18379612.00
SURG cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 207240.00
SURG balance_sheet (annual, 2023-12-31) — Properties: 0.00
SURG cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 0.00
SURG cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
SURG cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: 0.00
SURG cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
SURG cash_flow (annual, 2023-12-31) — Purchase Of PPE: 0.00
SURG balance_sheet (annual, 2023-12-31) — Receivables: 9536074.00
SURG income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 101455858.00
SURG income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1107582.00
SURG cash_flow (annual, 2023-12-31) — Repayment Of Debt: -2626875.00
SURG cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
SURG balance_sheet (annual, 2023-12-31) — Restricted Cash: 0.00
SURG balance_sheet (annual, 2023-12-31) — Retained Earnings: -15186203.00
SURG income_statement (annual, 2023-12-31) — Salaries And Wages: 6342955.00
SURG cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
SURG income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 152851.00
SURG income_statement (annual, 2023-12-31) — Selling General And Administration: 15713008.00
SURG balance_sheet (annual, 2023-12-31) — Share Issued: 14403261.00
SURG income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
SURG cash_flow (annual, 2023-12-31) — Stock Based Compensation: 566710.00
SURG balance_sheet (annual, 2023-12-31) — Stockholders Equity: 28249220.00
SURG balance_sheet (annual, 2023-12-31) — Tangible Book Value: 23916544.00
SURG income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
SURG income_statement (annual, 2023-12-31) — Tax Provision: -2265000.00
SURG income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
SURG balance_sheet (annual, 2023-12-31) — Total Assets: 41925307.00
SURG balance_sheet (annual, 2023-12-31) — Total Capitalization: 28709743.00
SURG balance_sheet (annual, 2023-12-31) — Total Debt: 5444499.00
SURG balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 28403464.00
SURG income_statement (annual, 2023-12-31) — Total Expenses: 118276448.00
SURG balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 13521843.00
SURG balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 8558646.00
SURG balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 816799.00
SURG income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 18865384.00
SURG balance_sheet (annual, 2023-12-31) — Total Tax Payable: 570000.00
SURG income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
SURG income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
SURG balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
SURG balance_sheet (annual, 2023-12-31) — Treasury Stock: 0.00
SURG balance_sheet (annual, 2023-12-31) — Working Capital: 20661617.00
SURG income_statement (annual, 2023-12-31) — Write Off: 0.00
SURG income_statement (quarterly, 2024-09-30) — Basic Average Shares: 19689010.00
SURG income_statement (quarterly, 2024-09-30) — Basic EPS: -0.73
SURG cash_flow (quarterly, 2024-09-30) — Capital Expenditure Reported: 0.00
SURG cash_flow (quarterly, 2024-09-30) — Change In Other Working Capital: 0.00
SURG balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 518189.00
SURG balance_sheet (quarterly, 2024-09-30) — Current Deferred Liabilities: 0.00
SURG balance_sheet (quarterly, 2024-09-30) — Current Deferred Revenue: 0.00
SURG income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 19689010.00
SURG income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.73
SURG income_statement (quarterly, 2024-09-30) — Gain On Sale Of Security: 124918.00
SURG balance_sheet (quarterly, 2024-09-30) — Income Tax Payable: 100000.00
SURG balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 498273.00
SURG balance_sheet (quarterly, 2024-09-30) — Investmentsin Associatesat Cost: 498273.00
SURG balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 498273.00
SURG cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: 0.00
SURG balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Assets: 0.00
SURG balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 0.00
SURG cash_flow (quarterly, 2024-09-30) — Operating Gains Losses: 0.00
SURG income_statement (quarterly, 2024-09-30) — Other Income Expense: -69705.00
SURG cash_flow (quarterly, 2024-09-30) — Other Non Cash Items: -68551.00
SURG income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: 239.00
SURG balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 10068506.00
SURG income_statement (quarterly, 2024-09-30) — Other Special Charges: 194862.00
SURG income_statement (quarterly, 2024-09-30) — Special Income Charges: -194862.00
SURG balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 100000.00
SURG income_statement (quarterly, 2024-09-30) — Total Unusual Items: -69944.00
SURG income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: -69944.00
SURG income_statement (annual, 2024-12-31) — +Operating Expense: 27458152.00
SURG income_statement (annual, 2024-12-31) — +Total Revenue: 60881173.00
SURG balance_sheet (annual, 2024-12-31) — Accounts Payable: 3929195.00
SURG balance_sheet (annual, 2024-12-31) — Accounts Receivable: 3000209.00
SURG balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1016139.00
SURG balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 76842878.00
SURG balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
SURG balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
SURG cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 222830.00
SURG cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 222830.00
SURG cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 1681649.00
SURG income_statement (annual, 2024-12-31) — Basic Average Shares: 19119181.00
SURG income_statement (annual, 2024-12-31) — Basic EPS: -2.39
SURG cash_flow (annual, 2024-12-31) — Beginning Cash Position: 14622060.00
SURG cash_flow (annual, 2024-12-31) — Capital Expenditure: -518189.00
SURG cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: 0.00
SURG cash_flow (quarterly, 2024-12-31) — Capital Expenditure Reported: 0.00
SURG balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 567301.00
SURG balance_sheet (annual, 2024-12-31) — Capital Stock: 20435.00
SURG balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 11790389.00
SURG balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 11790389.00
SURG balance_sheet (annual, 2024-12-31) — Cash Financial: 11790389.00
SURG balance_sheet (quarterly, 2024-12-31) — Cash Financial: 11790389.00
SURG cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 22483508.00
SURG cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -3004576.00
SURG cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -21310603.00
SURG cash_flow (annual, 2024-12-31) — Change In Account Payable: -2866313.00
SURG cash_flow (annual, 2024-12-31) — Change In Income Tax Payable: -570000.00
SURG cash_flow (quarterly, 2024-12-31) — Change In Income Tax Payable: -100000.00
SURG cash_flow (annual, 2024-12-31) — Change In Inventory: 7265229.00
SURG cash_flow (quarterly, 2024-12-31) — Change In Inventory: 6581773.00
SURG cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 148665.00
SURG cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 2815000.00
SURG cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: 0.00
SURG cash_flow (annual, 2024-12-31) — Change In Payable: -3436313.00
SURG cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -3436313.00
SURG cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -136427.00
SURG cash_flow (annual, 2024-12-31) — Change In Receivables: 6535865.00
SURG cash_flow (annual, 2024-12-31) — Change In Tax Payable: -570000.00
SURG cash_flow (quarterly, 2024-12-31) — Change In Tax Payable: -100000.00
SURG cash_flow (annual, 2024-12-31) — Change In Working Capital: 13192019.00
SURG cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 6535865.00
SURG cash_flow (annual, 2024-12-31) — Changes In Cash: -1831671.00
SURG balance_sheet (annual, 2024-12-31) — Common Stock: 20435.00
SURG balance_sheet (annual, 2024-12-31) — Common Stock Equity: 15315919.00
SURG cash_flow (annual, 2024-12-31) — Common Stock Issuance: 17249994.00
SURG cash_flow (annual, 2024-12-31) — Common Stock Payments: -631967.00
SURG cash_flow (quarterly, 2024-12-31) — Common Stock Payments: -146836.00
SURG income_statement (annual, 2024-12-31) — Cost Of Revenue: 75205372.00
SURG balance_sheet (annual, 2024-12-31) — Current Assets: 17870323.00
SURG balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 248069.00
SURG balance_sheet (annual, 2024-12-31) — Current Debt: 1689367.00
SURG balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 1937436.00
SURG balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 0.00
SURG balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 0.00
SURG balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 0.00
SURG balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 0.00
SURG balance_sheet (annual, 2024-12-31) — Current Liabilities: 6059476.00
SURG balance_sheet (annual, 2024-12-31) — Current Notes Payable: 0.00
SURG balance_sheet (quarterly, 2024-12-31) — Current Notes Payable: 0.00
SURG cash_flow (annual, 2024-12-31) — Depreciation: 1069420.00
SURG cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1292250.00
SURG income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 1165279.00
SURG cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1292250.00
SURG income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 1165279.00
SURG income_statement (annual, 2024-12-31) — Diluted Average Shares: 19119181.00
SURG income_statement (annual, 2024-12-31) — Diluted EPS: -2.39
SURG income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -45729224.00
SURG balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 192845.00
SURG income_statement (annual, 2024-12-31) — EBIT: -42513574.00
SURG income_statement (annual, 2024-12-31) — EBITDA: -41221324.00
SURG income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 33864.00
SURG income_statement (quarterly, 2024-12-31) — Earnings From Equity Interest: 0.00
SURG cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: -33864.00
SURG cash_flow (quarterly, 2024-12-31) — Earnings Losses From Equity Investments: 0.00
SURG cash_flow (annual, 2024-12-31) — End Cash Position: 12790389.00
SURG cash_flow (annual, 2024-12-31) — Financing Cash Flow: 22483508.00
SURG cash_flow (annual, 2024-12-31) — Free Cash Flow: -21828792.00
SURG cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -13613.00
SURG income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 369162.00
SURG income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 244244.00
SURG income_statement (annual, 2024-12-31) — General And Administrative Expense: 26183869.00
SURG balance_sheet (annual, 2024-12-31) — Goodwill: 3300000.00
SURG balance_sheet (quarterly, 2024-12-31) — Goodwill: 3300000.00
SURG balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 4772962.00
SURG balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 3000209.00
SURG balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 3000209.00
SURG balance_sheet (annual, 2024-12-31) — Gross PPE: 2172008.00
SURG income_statement (annual, 2024-12-31) — Gross Profit: -14324199.00
SURG income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 1183376.00
SURG cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 0.00
SURG cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 0.00
SURG balance_sheet (annual, 2024-12-31) — Income Tax Payable: 0.00
SURG balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 0.00